Cairn Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.56M Sell
2,785
-200
-7% -$203K 1.27% 28
2025
Q4
$3.21M Hold
2,985
1.52% 27
2025
Q3
$2.28M Hold
2,985
1.04% 32
2025
Q2
$2.33M Hold
2,985
1.22% 29
2025
Q1
$2.46M Sell
2,985
-50
-2% -$41.6K 1.39% 28
2024
Q4
$2.34M Sell
3,035
-495
-14% -$410K 1.38% 25
2024
Q3
$3.13M Sell
3,530
-115
-3% -$103K 1.73% 24
2024
Q2
$3.3M Buy
3,645
+65
+2% +$52K 1.93% 22
2024
Q1
$2.79M Sell
3,580
-400
-10% -$285K 1.6% 23
2023
Q4
$2.32M Sell
3,980
-26
-0.6% -$15.2K 1.45% 22
2023
Q3
$2.15M Buy
4,006
+26
+0.7% +$13.4K 1.43% 22
2023
Q2
$1.87M Hold
3,980
1.21% 26
2023
Q1
$1.37M Sell
3,980
-261
-6% -$88K 0.95% 32
2022
Q4
$1.55M Buy
4,241
+621
+17% +$220K 1.16% 30
2022
Q3
$1.17M Sell
3,620
-435
-11% -$138K 0.95% 33
2022
Q2
$1.31M Sell
4,055
-2,586
-39% -$776K 1.02% 36
2022
Q1
$2.39M Sell
6,641
-10
-0.2% -$2.57K 1.52% 23
2021
Q4
$1.84M Sell
6,651
-110
-2% -$27.9K 1.27% 29
2021
Q3
$1.56M Hold
6,761
1.16% 29
2021
Q2
$1.55M Sell
6,761
-2,505
-27% -$503K 1.14% 29
2021
Q1
$1.73M Sell
9,266
-395
-4% -$77.3K 1.44% 26
2020
Q4
$1.63M Buy
9,661
+560
+6% +$83.6K 1.54% 25
2020
Q3
$1.35M Sell
9,101
-240
-3% -$37.1K 1.43% 27
2020
Q2
$1.53M Sell
9,341
-725
-7% -$111K 1.86% 20
2020
Q1
$1.4M Sell
10,066
-45
-0.4% -$6.18K 2.08% 17
2019
Q4
$1.33M Buy
+10,111
New +$1.17M 1.32% 36

Other funds holding LLY

Cairn Investment Group's LLY Position: Q1 2026 in Review

Cairn Investment Group reduced its Eli Lilly (LLY) stake by 6.7% in Q1 2026, selling an estimated $203K and leaving 2,785 shares worth $2.56M. The position accounts for 1.27% of the portfolio, ranked #28.

Cairn Investment Group first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.3M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cairn Investment Group held 2,785 shares of Eli Lilly worth $2.56M as of Q1 2026.
  • Cairn Investment Group sold 200 Eli Lilly shares in Q1 2026, an estimated $203K.
  • Eli Lilly made up 1.27% of Cairn Investment Group's portfolio in Q1 2026, its #28 holding.
  • Cairn Investment Group first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • Cairn Investment Group's Eli Lilly position peaked at $3.3M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cairn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.